Restoring Safeguards for Dangerous Abortion Drugs Act
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 5646 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 5646 To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 30, 2025 Mrs. Miller of Illinois (for herself, Mr. Moore of Alabama, Mrs. Biggs of South Carolina, Mr. Weber of Texas, Mr. Harrigan, Mr. Burchett, and Mr. LaMalfa) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Restoring Safeguards for Dangerous Abortion Drugs Act''. SEC. 2. DEFINITION. In this Act, the term ``covered medication'' means mifepristone, also known by the brand names, Mifeprex and Korlym, and the developmental code name, RU-486. SEC. 3. MIFEPRISTONE REMS. (a) In General.--Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services shall-- (1) withdraw approval of the risk evaluation and mitigation strategy pursuant to section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) for the covered medication that is in effect o
Health
← Back to Mary Miller's profile